556 related articles for article (PubMed ID: 30453253)
1. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.
Chaudhari U; Nemade H; Gaspar JA; Hescheler J; Hengstler JG; Sachinidis A
Arch Toxicol; 2016 Dec; 90(12):3087-3098. PubMed ID: 26842497
[TBL] [Abstract][Full Text] [Related]
3. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
4. A Specific Circulating MicroRNA Cluster Is Associated to Late Differential Cardiac Response to Doxorubicin-Induced Cardiotoxicity
Ruggeri C; Gioffré S; Chiesa M; Buzzetti M; Milano G; Scopece A; Castiglioni L; Pontremoli M; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Dis Markers; 2018; 2018():8395651. PubMed ID: 30627229
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicity.
Desai VG; Vijay V; Lee T; Han T; Moland CL; Phanavanh B; Herman EH; Stine K; Fuscoe JC
J Appl Toxicol; 2022 Sep; 42(9):1477-1490. PubMed ID: 35199358
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p.
Wang X; Cheng Z; Xu J; Feng M; Zhang H; Zhang L; Qian L
Life Sci; 2021 Jan; 265():118788. PubMed ID: 33245966
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA miR-215-5p Regulates Doxorubicin-induced Cardiomyocyte Injury by Targeting ZEB2.
Xiong X; He Q; Liu J; Dai R; Zhang H; Cao Z; Liao Y; Liu B; Zhou Y; Chen J; Chen M; Liu J
J Cardiovasc Pharmacol; 2021 Oct; 78(4):622-629. PubMed ID: 34282068
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity.
Holmgren G; Synnergren J; Andersson CX; Lindahl A; Sartipy P
Toxicol In Vitro; 2016 Aug; 34():26-34. PubMed ID: 27033315
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
Jing X; Yang J; Jiang L; Chen J; Wang H
Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
[TBL] [Abstract][Full Text] [Related]
11. Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.
Ruggeri C; Gioffré S; Achilli F; Colombo GI; D'Alessandra Y
Heart Fail Rev; 2018 Jan; 23(1):109-122. PubMed ID: 28944400
[TBL] [Abstract][Full Text] [Related]
12. Early biomarkers of doxorubicin-induced heart injury in a mouse model.
Desai VG; C Kwekel J; Vijay V; Moland CL; Herman EH; Lee T; Han T; Lewis SM; Davis KJ; Muskhelishvili L; Kerr S; Fuscoe JC
Toxicol Appl Pharmacol; 2014 Dec; 281(2):221-9. PubMed ID: 25448438
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-31-5p attenuates doxorubicin-induced cardiotoxicity via quaking and circular RNA Pan3.
Ji X; Ding W; Xu T; Zheng X; Zhang J; Liu M; Liu G; Wang J
J Mol Cell Cardiol; 2020 Mar; 140():56-67. PubMed ID: 32135167
[TBL] [Abstract][Full Text] [Related]
14. Imatinib-induced changes in the expression profile of microRNA in the plasma and heart of mice-A comparison with doxorubicin.
Hanousková B; Skála M; Brynychová V; Zárybnický T; Skarková V; Kazimírová P; Vernerová A; Souček P; Skálová L; Pudil R; Matoušková P
Biomed Pharmacother; 2019 Jul; 115():108883. PubMed ID: 31004989
[TBL] [Abstract][Full Text] [Related]
15. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
16. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425.
Guo L; Zheng X; Wang E; Jia X; Wang G; Wen J
Biomed Pharmacother; 2020 May; 125():109784. PubMed ID: 32092815
[TBL] [Abstract][Full Text] [Related]
17. Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity.
Zhu JN; Fu YH; Hu ZQ; Li WY; Tang CM; Fei HW; Yang H; Lin QX; Gou DM; Wu SL; Shan ZX
Sci Rep; 2017 Sep; 7(1):11879. PubMed ID: 28928469
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
[TBL] [Abstract][Full Text] [Related]
19. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
[TBL] [Abstract][Full Text] [Related]
20. Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart.
Volkova M; Palmeri M; Russell KS; Russell RR
Cardiovasc Res; 2011 May; 90(2):305-14. PubMed ID: 21233252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
